MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway

Affiliations

• ¹ Algarve Biomedical Center, Department of Biomedical Sciences and Medicine, Division of Oncology, University of Algarve, 8005-139 Faro, Portugal.
• ² Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
• ³ Translational Research Centre, Division of Medical Oncology, Oncology & Hematology Nucleus of Ceará, Hospital São Mateus, Fortaleza, CE, Brazil.
• ⁴ PhD Fellowship Program, Faculdade de Medicina do ABC, Santo André, SP, Brazil.
• ⁵ Division of Medical Oncology, São Paulo University Hospital, Federal University of São Paulo (EPM/UNIFESP), São Paulo, SP, Brazil.
• ⁶ MSL at Hoffmann-La Roche, São Paulo, SP, Brazil.
• ⁷ Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.
• ⁸ Faculty of Nutrition and Food Sciences, University of Porto, 4200-319 Porto, Portugal.